BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318 | -17.4% | 8,426 | -0.1% | 0.06% | -13.8% |
| Q2 2023 | $385 | -58.2% | 8,431 | -58.5% | 0.06% | -59.9% |
| Q1 2023 | $922 | +7.3% | 20,299 | +7.3% | 0.16% | +5.2% |
| Q4 2022 | $859 | -99.9% | 18,924 | +81.9% | 0.15% | +28.3% |
| Q3 2022 | $578,000 | +0.5% | 10,404 | +18.0% | 0.12% | -0.8% |
| Q2 2022 | $575,000 | +1269.0% | 8,816 | +1523.6% | 0.12% | +1412.5% |
| Q1 2022 | $42,000 | -2.3% | 543 | +8.6% | 0.01% | 0.0% |
| Q4 2021 | $43,000 | +7.5% | 500 | 0.0% | 0.01% | +14.3% |
| Q3 2021 | $40,000 | 0.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $40,000 | -4.8% | 500 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $42,000 | +5.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $40,000 | 0.0% | 500 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $40,000 | -7.0% | 500 | 0.0% | 0.01% | -10.0% |
| Q2 2020 | $43,000 | +4.9% | 500 | 0.0% | 0.01% | -9.1% |
| Q1 2020 | $41,000 | -10.9% | 500 | -9.3% | 0.01% | -8.3% |
| Q4 2019 | $46,000 | -4.2% | 551 | 0.0% | 0.01% | -7.7% |
| Q3 2019 | $48,000 | +860.0% | 551 | +548.2% | 0.01% | +550.0% |
| Q3 2017 | $5,000 | -96.1% | 85 | -96.0% | 0.00% | -95.7% |
| Q2 2017 | $128,000 | +11.3% | 2,106 | -4.7% | 0.05% | +4.5% |
| Q1 2017 | $115,000 | -10.2% | 2,211 | -23.7% | 0.04% | -25.4% |
| Q4 2016 | $128,000 | -3.0% | 2,896 | -0.8% | 0.06% | -14.5% |
| Q2 2016 | $132,000 | +10.0% | 2,919 | +0.0% | 0.07% | +7.8% |
| Q1 2016 | $120,000 | +8.1% | 2,918 | +0.3% | 0.06% | -1.5% |
| Q4 2015 | $111,000 | +15.6% | 2,908 | +0.0% | 0.06% | +12.1% |
| Q3 2015 | $96,000 | -52.7% | 2,907 | +0.1% | 0.06% | -49.6% |
| Q2 2015 | $203,000 | +111.5% | 2,905 | +106.6% | 0.12% | +101.8% |
| Q1 2015 | $96,000 | -1.0% | 1,406 | +0.4% | 0.06% | -21.9% |
| Q4 2014 | $97,000 | – | 1,401 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |